Voloridge Investment Management
LFST icon

Voloridge Investment Management’s Lifestance Health LFST Stock Holding History

Voloridge Investment Management’s Portfolio LFST Stock Details LFST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-62,831
Closed -$346K – 1262
2025
Q3 		$346K Buy
+62,831
New +$308K ﹤0.01% 1118
2024
Q2 		– Sell
-306,520
Closed -$1.89M – 1299
2024
Q1 		$1.89M Buy
+306,520
New +$2.06M 0.01% 868
2022
Q3 		– Sell
-75,843
Closed -$422K – 1521
2022
Q2 		$422K Sell
75,843
-151,402
-67% -$1.16M ﹤0.01% 1316
2022
Q1 		$2.3M Buy
227,245
+140,969
+163% +$1.24M 0.01% 899
2021
Q4 		$821K Buy
+86,276
New +$915K ﹤0.01% 1315
2021
Q3 		– Sell
-26,764
Closed -$746K – 1760
2021
Q2 		$746K Buy
+26,764
New +$707K 0.01% 1342

Other funds holding LFST

TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SP
Summit Partners Boston, Massachusetts $670M AUM 6.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SPIG
Silversmith Partners I GP Boston, Massachusetts $39.2M AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Voloridge Investment Management's LFST Position: Q4 2025 in Review

Voloridge Investment Management sold out of Lifestance Health (LFST) in Q4 2025, closing a stake of 62,831 shares — an estimated $346K sold.

Voloridge Investment Management first reported a position in LFST in Q2 2021 and held it in 6 quarters. The position peaked at $2.3M in Q1 2022. 204 funds tracked by Wall St. Rank hold LFST as of Q4 2025.

  • Voloridge Investment Management reported no remaining Lifestance Health position as of Q4 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 62,831 Lifestance Health shares in Q4 2025, an estimated $346K.
  • Voloridge Investment Management first reported a position in Lifestance Health in Q2 2021 and held it in 6 quarters.
  • Voloridge Investment Management's Lifestance Health position peaked at $2.3M in Q1 2022.
  • 204 funds tracked by Wall St. Rank held Lifestance Health as of Q4 2025.

Based on Voloridge Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.